Chongqing Lummy Pharmaceutical Co., Ltd. (SHE:300006)
China · Delayed Price · Currency is CNY 6.21
+0.03 (0.49%)
Apr 15, 2026, 3:08 PM CST
SHE:300006 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Net Income | -134.71 | -87.8 | -8.93 | -68.71 | -100.53 |
Depreciation & Amortization | 51.92 | 55.8 | 72.77 | 76.41 | 74.76 |
Other Amortization | 1.95 | 1.26 | 2.65 | 1.78 | 1.42 |
Loss (Gain) From Sale of Assets | -0.03 | -0.49 | -0.45 | -0.25 | 0.03 |
Asset Writedown & Restructuring Costs | 62.35 | 25.75 | 0.71 | 0.09 | 0.51 |
Loss (Gain) From Sale of Investments | 21.14 | 18.88 | -85.74 | -5.78 | -47.92 |
Provision & Write-off of Bad Debts | 4.28 | 2.06 | -1.69 | -5.59 | -1.42 |
Other Operating Activities | 7.25 | 6.98 | -14.59 | 44.54 | 66.98 |
Change in Accounts Receivable | 49.27 | 239.87 | 51.39 | 142.18 | -54.29 |
Change in Inventory | 39.58 | 0.99 | 27.64 | -46.66 | 63.34 |
Change in Accounts Payable | -53.33 | -75.35 | -50.76 | -20.24 | 118.1 |
Change in Other Net Operating Assets | - | -0.3 | 82.59 | -51.46 | - |
Operating Cash Flow | 26.04 | 185.03 | 81.53 | 57.13 | 108.28 |
Operating Cash Flow Growth | -85.93% | 126.94% | 42.70% | -47.24% | -51.78% |
Capital Expenditures | -41.75 | -78.62 | -59.32 | -68.18 | -38.66 |
Sale of Property, Plant & Equipment | 0.31 | 0.04 | 0.16 | 0 | 0.74 |
Cash Acquisitions | - | -11.01 | - | - | - |
Divestitures | 0.78 | - | -12.29 | - | 78.12 |
Investment in Securities | -19.3 | 64.22 | -60.29 | 80.2 | 114.3 |
Other Investing Activities | 8.55 | 7.07 | 4.64 | 1.81 | 2.69 |
Investing Cash Flow | -51.4 | -18.31 | -127.11 | 13.82 | 157.19 |
Long-Term Debt Issued | 294.95 | 391.6 | 294.9 | 352.5 | 171 |
Short-Term Debt Repaid | - | - | - | - | -180.91 |
Long-Term Debt Repaid | -430.79 | -181.23 | -362.86 | -206.88 | -1,084 |
Total Debt Repaid | -430.79 | -181.23 | -362.86 | -206.88 | -1,265 |
Net Debt Issued (Repaid) | -135.84 | 210.37 | -67.96 | 145.62 | -1,094 |
Issuance of Common Stock | - | - | - | - | 1,065 |
Common Dividends Paid | -12.35 | -10.76 | -11.8 | -17.47 | -29.08 |
Other Financing Activities | 30.22 | -9.67 | -1.48 | 37.91 | 94.2 |
Financing Cash Flow | -117.96 | 189.94 | -81.24 | 166.07 | 36.05 |
Foreign Exchange Rate Adjustments | -0.96 | 0.44 | 0.57 | 2.77 | -0.86 |
Net Cash Flow | -144.29 | 357.1 | -126.25 | 239.79 | 300.67 |
Free Cash Flow | -15.71 | 106.41 | 22.21 | -11.05 | 69.63 |
Free Cash Flow Growth | - | 379.04% | - | - | -61.32% |
Free Cash Flow Margin | -2.02% | 13.37% | 2.48% | -1.25% | 5.68% |
Free Cash Flow Per Share | -0.01 | 0.10 | 0.02 | -0.01 | 0.07 |
Cash Income Tax Paid | 77.39 | 126.87 | 132.63 | 114.96 | 166.12 |
Levered Free Cash Flow | 19.01 | 68.26 | 17.68 | 211.44 | -66.92 |
Unlevered Free Cash Flow | 27.62 | 75.21 | 25.48 | 224.16 | -46.87 |
Change in Working Capital | 11.88 | 162.6 | 116.79 | 14.64 | 114.46 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.